COST NO FEENO SET ASIDE USED.

COLORADO STATE UNIVERSITY - COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.

PIID: 75N93020C00053Solicitation ID: HHS-NIH-NIAID-BAA2020-1

Signed Date: Jan 6, 2026Effective Date: Sep 1, 2020End Date: Closes in 595 days

Award $

$6.3M

Vendor

COLORADO STATE UNIVERSITY

NAICS

541715

Signed Date

Jan 6, 2026

Key Details

Dollars Obligated

$6.3M

Base & All Options

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Product Service Code

AJ12 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

FORT COLLINS, CO, 805232002, CD-CO-02

COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.

On Jan 6, 2026, Department of Health and Human Services obligated $6,280,811 to COLORADO STATE UNIVERSITY for covid-19. to develop and manufacture an inactivated virus vaccine using blood pathogen reduction technology.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 23 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in FORT COLLINS, CO. The contract is scheduled through Apr 30, 2028.